829 related articles for article (PubMed ID: 31359293)
21. Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers.
Zabeti Touchaei A; Vahidi S; Samadani AA
Clin Exp Med; 2024 Jan; 24(1):29. PubMed ID: 38294554
[TBL] [Abstract][Full Text] [Related]
22. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review.
Saadh MJ; Allela OQB; Sattay ZJ; Al Zuhairi RAH; Ahmad H; Eldesoky GE; Adil M; Ali MS
Pathol Res Pract; 2024 Mar; 255():155158. PubMed ID: 38320438
[TBL] [Abstract][Full Text] [Related]
23. TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis.
Li C; Gao Y; Li Y; Ding D
Biochem Biophys Res Commun; 2017 Sep; 491(2):552-557. PubMed ID: 28302487
[TBL] [Abstract][Full Text] [Related]
24. Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer.
Wang L; Cho KB; Li Y; Tao G; Xie Z; Guo B
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744051
[TBL] [Abstract][Full Text] [Related]
25. Noncoding RNAs and Colorectal Cancer: A General Overview.
Sarraf JS; Puty TC; da Silva EM; Allen TSR; Sarraf YS; de Carvalho LEW; Adami F; de Oliveira EHC
Microrna; 2020; 9(5):336-345. PubMed ID: 33349228
[TBL] [Abstract][Full Text] [Related]
26. The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance.
Lampropoulou DI; Pliakou E; Aravantinos G; Filippou D; Gazouli M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163397
[TBL] [Abstract][Full Text] [Related]
27. Non-coding RNAs as emerging regulators and biomarkers in colorectal cancer.
Kishore C; Karunagaran D
Mol Cell Biochem; 2022 Jun; 477(6):1817-1828. PubMed ID: 35332394
[TBL] [Abstract][Full Text] [Related]
28. Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers.
Ebrahimi N; Hakimzadeh A; Bozorgmand F; Speed S; Manavi MS; Khorram R; Farahani K; Rezaei-Tazangi F; Mansouri A; Hamblin MR; Aref AR
Cell Cycle; 2023 Oct; 22(20):2302-2323. PubMed ID: 38009668
[TBL] [Abstract][Full Text] [Related]
29. Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs.
Lulli M; Napoli C; Landini I; Mini E; Lapucci A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362222
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
[TBL] [Abstract][Full Text] [Related]
31. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
Chen C; Tang X; Liu Y; Zhu J; Liu J
Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
[TBL] [Abstract][Full Text] [Related]
32. Two Novel Long Noncoding RNAs - RP11-296E3.2 and LEF1-AS1can - Separately Serve as Diagnostic and Prognostic Bio-Markers of Metastasis in Colorectal Cancer.
Shi Q; He Y; Zhang X; Li J; Cui G; Zhang X; Wang X
Med Sci Monit; 2019 Sep; 25():7042-7051. PubMed ID: 31536481
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNAs and endometrial cancer.
Liu H; Wan J; Chu J
Biomed Pharmacother; 2019 Nov; 119():109396. PubMed ID: 31505425
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells.
Li Y; Huang S; Li Y; Zhang W; He K; Zhao M; Lin H; Li D; Zhang H; Zheng Z; Huang C
Tumour Biol; 2016 Oct; 37(10):14205-14215. PubMed ID: 27553025
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy.
Wang M; Han D; Yuan Z; Hu H; Zhao Z; Yang R; Jin Y; Zou C; Chen Y; Wang G; Gao X; Wang X
Cell Death Dis; 2018 Nov; 9(12):1149. PubMed ID: 30451820
[TBL] [Abstract][Full Text] [Related]
36. Potentials of long non-coding RNAs as biomarkers of colorectal cancer.
Lv Y; Wang Y; Zhang Z; Bao J; Su H
Clin Transl Oncol; 2022 Sep; 24(9):1715-1731. PubMed ID: 35581419
[TBL] [Abstract][Full Text] [Related]
37. A Review on Theragnostic Applications of Micrornas and Long Non- Coding RNAs in Colorectal Cancer.
Jothimani G; Sriramulu S; Chabria Y; Sun XF; Banerjee A; Pathak S
Curr Top Med Chem; 2018; 18(30):2614-2629. PubMed ID: 30582478
[TBL] [Abstract][Full Text] [Related]
38. Microarray Analysis of Long Non-coding RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells.
Xiong W; Jiang YX; Ai YQ; Liu S; Wu XR; Cui JG; Qin JY; Liu Y; Xia YX; Ju YH; He WJ; Wang Y; Li YF; Hou Y; Wang L; Li WH
Asian Pac J Cancer Prev; 2015; 16(8):3395-402. PubMed ID: 25921151
[TBL] [Abstract][Full Text] [Related]
39. Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance.
Raei N; Safaralizadeh R; Hesseinpourfeizi M; Yazdanbod A; Pourfarzi F; Latifi-Navid S
Life Sci; 2021 Nov; 284():119933. PubMed ID: 34508759
[TBL] [Abstract][Full Text] [Related]
40. Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer.
Yang L; Zhang X; Hu G
Clin Transl Oncol; 2021 Nov; 23(11):2220-2236. PubMed ID: 34275108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
